Get started
OptimizeRx CorporationOptimizeRx CorporationOptimizeRx Corporation

OptimizeRx Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

OPRX chart


Full chart

OPRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪151.25 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.10 USD
Net income (FY)
‪−20.11 M‬ USD
Revenue (FY)
‪92.13 M‬ USD
Shares float
‪15.47 M‬
Beta (1Y)
2.10

Employees


Employees (FY)
129
Change (1Y)
−7 −5.15%
Revenue / Employee (1Y)
‪714.16 K‬ USD
Net income / Employee (1Y)
‪−155.89 K‬ USD

About OptimizeRx Corporation


Sector
Technology Services
Industry
Packaged Software
CEO
Stephen L. Silvestro
Website
optimizerx.com
Headquarters
Waltham
FIGI
BBG000HKQH91
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OPRX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as OPRX.

Frequently Asked Questions


The current price of OPRX is 8.13 USD — it has decreased by −5.54% in the past 24 hours. Watch OptimizeRx Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OptimizeRx Corporation stocks are traded under the ticker OPRX.
OPRX stock has fallen by −10.11% compared to the previous week, the month change is a 60.08% rise, over the last year OptimizeRx Corporation has showed a −27.60% decrease.
We've gathered analysts' opinions on OptimizeRx Corporation future price: according to them, OPRX price has a max estimate of 16.00 USD and a min estimate of 6.00 USD. Watch OPRX chart and read a more detailed OptimizeRx Corporation stock forecast: see what analysts think of OptimizeRx Corporation and suggest that you do with its stocks.
OPRX reached its all-time high on Dec 18, 2006 with the price of 6,000.60 USD, and its all-time low was 0.60 USD and was reached on Sep 24, 2009. View more price dynamics on OPRX chart.
See other stocks reaching their highest and lowest prices.
OPRX stock is 6.17% volatile and has beta coefficient of 2.10. Track OptimizeRx Corporation stock price on the chart and check out the list of the most volatile stocks — is OptimizeRx Corporation there?
Today OptimizeRx Corporation has the market capitalization of ‪151.25 M‬, it has decreased by −8.55% over the last week.
Yes, you can track OptimizeRx Corporation financials in yearly and quarterly reports right on TradingView.
OptimizeRx Corporation is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
OPRX earnings for the last quarter are 0.30 USD per share, whereas the estimation was 0.27 USD resulting in a 10.35% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about OptimizeRx Corporation earnings.
OptimizeRx Corporation revenue for the last quarter amounts to ‪32.32 M‬ USD, despite the estimated figure of ‪30.70 M‬ USD. In the next quarter, revenue is expected to reach ‪18.69 M‬ USD.
OPRX net income for the last quarter is ‪−77.00 K‬ USD, while the quarter before that showed ‪−9.12 M‬ USD of net income which accounts for 99.16% change. Track more OptimizeRx Corporation financial stats to get the full picture.
No, OPRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 2, 2025, the company has 129 employees. See our rating of the largest employees — is OptimizeRx Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OptimizeRx Corporation EBITDA is ‪−1.89 M‬ USD, and current EBITDA margin is 2.59%. See more stats in OptimizeRx Corporation financial statements.
Like other stocks, OPRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OptimizeRx Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OptimizeRx Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OptimizeRx Corporation stock shows the sell signal. See more of OptimizeRx Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.